AVANIR Pharmaceuticals to Announce Fourth Fiscal Quarter and Year-End 2001 Results On Dec. 18.Business Editors SAN DIEGO--(BUSINESS WIRE)--Dec. 6, 2001 AVANIR Pharmaceuticals (AMEX AMEX See: American Stock Exchange :AVN AVN Aviation AVN Avenue AVN Adult Video News AVN Avascular Necrosis AVN Atrioventricular Node AVN Aviation Model (weather forecast model, now Global Forecast System) AVN Air Vanuatu (ICAO code) ) will announce financial results for the fourth fiscal quarter and year ended September 30, 2001 after the market closes on Tuesday, December 18, 2001. Following the release, management will host a conference call with a simultaneous webcast at 1:30 p.m. Pacific/4:30 p.m. Eastern to discuss fourth fiscal quarter and year-end 2001 operating performance and outlook. The webcast, featuring President and Chief Executive Officer Gerald J. Yakatan, Ph.D. and Vice President and Chief Financial Officer Gregory Hanson, will be available live via the Internet by accessing AVANIR's Web site at www.avanir.com. The live webcast will also be available at CCBN's www.companyboardroom.com. Please go to either web site at least ten minutes early to register, download and install any necessary audio software. For those who cannot listen to the live broadcast, the online replays will be available for 90 days, or a phone replay will be available through December 27, 2001, by dialing (888) 266-2086 and entering the passcode No. 5710623. AVANIR Pharmaceuticals, based in San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. , is a diversified biopharmaceutical company with an FDA-approved drug currently on the market. AVANIR is engaged in research, development, commercialization, licensing and sales of innovative drug products and antibody generation services. The company's Web site is www.avanir.com. AVANIR news releases, including any forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. contained therein, should be reviewed in conjunction with the company's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and other publicly available information regarding the company. Copies of such information are available from the company upon request. Such publicly available information sets forth many risks and uncertainties related to the company's business and technology. Forward-looking statements often contain such words like "estimate," "anticipate," "believe," "plan" or "expect." Research findings are not always supportable by evidence obtained from subsequent clinical trials. Final review decisions made by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other regulatory agencies regulatory agency Independent government commission charged by the legislature with setting and enforcing standards for specific industries in the private sector. The concept was invented by the U.S. concerning clinical trial results are unpredictable and outside the influence and/or control of the company. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion